7MED Welcomes Strategic Investment from PVP Ventures to Accelerate Healthcare Innovation

8th September 2025Prem Malhotra Blog News & Updates

_{Strengthening Our Mission to Deliver Quality Renal and Urology Care Across India}

A New Chapter fo7MED

We are proud to announce that PVP Ventures Limited, a forward-looking investment company, has acquired a 41.23% strategic stake in 7Med India Pvt. Ltd. and Epitome Group of Hospitals. This investment marks a significant milestone in our journey and further empowers our commitment to accessible, high-quality, and technology-driven healthcare.

The transaction, announced on August 29, 2025, lays the foundation for long-term collaboration, with plans to grow the partnership.

Who We Are: The 7MED Impact

Founded with the mission of transforming renal care in India, 7MED and Epitome Hospitals operate a network of:

22 dialysis centers (both standalone and within hospitals)
4 super-specialty hospitals
Coverage across six Indian states, focused on nephrology, urology, and kidney transplantation

With a team of 450+ medical professionals, we’ve proudly conducted over 1 million dialysis procedures, making us a trusted name in advanced kidney care.

About Our Strategic Partner: PVP Ventures

PVP Ventures is actively building a technology-led healthcare ecosystem, investing in high-potential healthcare businesses with strong clinical foundations. Their portfolio spans oncology, diagnostics, genomics, dialysis, teleradiology, and senior care. Their focus on Tier II and Tier III cities aligns with our own mission to bridge the healthcare access gap in underserved markets.

This investment in 7MED is part of PVP’s broader strategy to build a “house of healthcare brands,” fueling innovation and scale in India’s health infrastructure.

Shared Vision: Growth and Impact

With this partnership, 7MED aims to:

Expand operations to new geographies
Enhance clinical capabilities through technology and process innovation
Invest in infrastructure, training, and digital tools
Scale our services with a target of 5X EBITDA growth over the next four years

We believe this collaboration will bring significant value not only to our organization but more importantly—to the millions of patients we serve.

Leadership Perspectives

Gaurav Davda, Head of M&A and Strategy at PVP Ventures, commented:

“This transaction is a key milestone in our journey to build a powerful house of healthcare brands with a focus on Tier II and Tier III markets. We are excited to partner with 7MED, a company that aligns with our values and vision for healthcare access and innovation.”

Dr. Vijay Kher, Chairman of Epitome Hospitals and shareholder in 7MED, added:

“This partnership allows us to scale our mission of patient-centric kidney care, leveraging PVP’s strategic insights and investment to improve outcomes across India.”

7MED in the News

Our strategic partnership with PVP Ventures has been featured in leading media outlets: